{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:05:08Z","timestamp":1792695908068,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jocd.2019.07.010","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T02:23:29Z","timestamp":1563330209000},"page":"489-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Repeating Measurement of Bone Mineral Density when Monitoring with Dual-energy X-ray Absorptiometry: 2019 ISCD Official Position"],"prefix":"10.1016","volume":"22","author":[{"given":"David L.","family":"Kendler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Compston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Michael","family":"Lewiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jocd.2019.07.010_bib0001","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","article-title":"Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD","volume":"18","author":"Shepherd","year":"2015","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jocd.2016.03.003","article-title":"Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance","volume":"19","author":"Lewiecki","year":"2016","journal-title":"J Clin Densitom"},{"issue":"Suppl 114(5)","key":"10.1016\/j.jocd.2019.07.010_bib0003","first-page":"115","article-title":"Current imaging techniques in osteoporosis","volume":"36","author":"Carey","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jocd.2019.07.010_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2016.12.013","article-title":"DXA: 30 years and counting: introduction to the 30th anniversary issue","volume":"104","author":"Lewiecki","year":"2017","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jocd.2019.07.010_bib0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jocd.2015.06.012","article-title":"Clinical use of quantitative computed tomography (QCT) of the hip in the management of osteoporosis in adults: the 2015 ISCD Official Positions-Part I","volume":"18","author":"Engelke","year":"2015","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0006","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jocd.2007.12.012","article-title":"Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions","volume":"11","author":"Hans","year":"2008","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jocd.2007.12.011","article-title":"Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions","volume":"11","author":"Krieg","year":"2008","journal-title":"J Clin Densitom"},{"issue":"24","key":"10.1016\/j.jocd.2019.07.010_bib0008","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMsa066253","article-title":"Relationship between number of medical conditions and quality of care","volume":"356","author":"Higashi","year":"2007","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jocd.2019.07.010_bib0009","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of health care delivered to adults in the United States","volume":"348","author":"McGlynn","year":"2003","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jocd.2019.07.010_bib0010","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3899\/jrheum.090980","article-title":"Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis","volume":"37","author":"Katchamart","year":"2010","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0011","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/aje\/kwx149","article-title":"Use of repeated blood pressure and cholesterol measurements to improve cardiovascular disease risk prediction: an individual-participant-data meta-analysis","volume":"186","author":"Paige","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0012","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.vaccine.2011.11.099","article-title":"To TST or not to TST: is tuberculin skin testing necessary before BCG immunisation in children","volume":"30","author":"Ritz","year":"2012","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.jocd.2019.07.010_bib0013","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini","year":"2018","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.jocd.2019.07.010_bib0014","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1385\/JCD:5:3S:S29","article-title":"What is the role of serial bone mineral density measurements in patient management?","volume":"5","author":"Lenchik","year":"2002","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2019.07.010_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2017.05.021","article-title":"Utility of DXA for monitoring, technical aspects of DXA BMD measurement and precision testing","volume":"104","author":"Carey","year":"2017","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0016","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jbmr.1673","article-title":"Bone strength and surrogate markers: the first, second, and third fiddle","volume":"27","author":"Miller","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0017","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1385\/JCD:8:4:371","article-title":"Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry","volume":"8","author":"Baim","year":"2005","journal-title":"J Clin Densitom"},{"issue":"6","key":"10.1016\/j.jocd.2019.07.010_bib0018","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","article-title":"International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions","volume":"43","author":"Lewiecki","year":"2008","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0019","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00198-008-0615-1","article-title":"Optimal decision criterion for detecting change in bone mineral density during serial monitoring: a Bayesian approach","volume":"19","author":"Sadatsafavi","year":"2008","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0020","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0021","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.jocd.2019.07.010_bib0022","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1377\/hlthaff.2011.0233","article-title":"Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures","volume":"30","author":"King","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0023","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s11606-017-4094-y","article-title":"Incidence and predictors of repeat bone mineral densitometry: a longitudinal cohort study","volume":"32","author":"White VanGompel","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"9","key":"10.1016\/j.jocd.2019.07.010_bib0024","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00198-014-2725-2","article-title":"Overuse of short-interval bone densitometry: assessing rates of low-value care","volume":"25","author":"Morden","year":"2014","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1359\/jbmr.081116","article-title":"Bridging the osteoporosis quality chasm","volume":"24","author":"Curtis","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0026","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10654-009-9381-4","article-title":"Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women","volume":"24","author":"Bruyere","year":"2009","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"10.1016\/j.jocd.2019.07.010_bib0027","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jama.2013.277817","article-title":"Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture","volume":"310","author":"Berry","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0028","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archinte.167.2.155","article-title":"Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures","volume":"167","author":"Hillier","year":"2007","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0029","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1359\/JBMR.050704","article-title":"Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study","volume":"20","author":"Sornay-Rendu","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jocd.2019.07.010_bib0030","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1359\/JBMR.050215","article-title":"Femoral neck bone loss predicts fracture risk independent of baseline BMD","volume":"20","author":"Nguyen","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0031","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1359\/jbmr.081004","article-title":"Association between change in BMD and fragility fracture in women and men","volume":"24","author":"Berger","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jocd.2019.07.010_bib0032","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2019.07.010_bib0033","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa1107142","article-title":"Bone-density testing interval and transition to osteoporosis in older women","volume":"366","author":"Gourlay","year":"2012","journal-title":"N Engl J Med"},{"issue":"8914","key":"10.1016\/j.jocd.2019.07.010_bib0034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","article-title":"Generalised bone loss in patients with early rheumatoid arthritis","volume":"344","author":"Gough","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000052","article-title":"Inflammation, bone loss and fracture risk in spondyloarthritis","volume":"1","author":"Briot","year":"2015","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0036","doi-asserted-by":"crossref","first-page":"e81124","DOI":"10.1371\/journal.pone.0081124","article-title":"Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post-injury osteoporosis in spinal cord injury patients \u2013 a systematic review and meta-analysis","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.jocd.2019.07.010_bib0037","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198606263142605","article-title":"Involutional osteoporosis","volume":"314","author":"Riggs","year":"1986","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0038","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00198-010-1181-x","article-title":"Depression, fracture risk, and bone loss: a meta-analysis of cohort studies","volume":"21","author":"Wu","year":"2010","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0039","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0041","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","article-title":"Bone loss and fracture risk associated with cancer therapy","volume":"11","author":"Guise","year":"2006","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0042","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/QAD.0000000000001372","article-title":"Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients","volume":"31","author":"Tinago","year":"2017","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jocd.2019.07.010_bib0043","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s001980050137","article-title":"Rates of growth and loss of bone mineral in the spine and femoral neck in white females","volume":"9","author":"Hui","year":"1999","journal-title":"Osteoporos Int"},{"issue":"6808","key":"10.1016\/j.jocd.2019.07.010_bib0044","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.303.6808.961","article-title":"Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study","volume":"303","author":"Hansen","year":"1991","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0045","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1359\/jbmr.2000.15.10.1974","article-title":"Rate of bone loss is associated with mortality in older women: a prospective study","volume":"15","author":"Kado","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2019.07.010_bib0046","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bone.2019.01.017","article-title":"Lower baseline value and greater decline in BMD as independent risk factors for mortality in community dwelling elderly","volume":"121","author":"Kim","year":"2019","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0047","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.1671","article-title":"Change in hip bone mineral density and risk of subsequent fractures in older men","volume":"27","author":"Cawthon","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0048","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1210\/jc.2014-3777","article-title":"Why does rate of bone density loss not predict fracture risk?","volume":"100","author":"Leslie","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0049","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jocd.2019.07.010_bib0050","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.1996.03540170033029","article-title":"Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen\/progestin interventions (PEPI) trial","volume":"276","year":"1996","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jocd.2019.07.010_bib0051","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"issue":"9041","key":"10.1016\/j.jocd.2019.07.010_bib0052","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jocd.2019.07.010_bib0053","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jocd.2019.07.010_bib0054","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.289.19.2525","article-title":"Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial","volume":"289","author":"Greenspan","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jocd.2019.07.010_bib0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0056","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0057","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jocd.2019.07.010_bib0058","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0059","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0060","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.jocd.2019.07.010_bib0061","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0062","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jocd.2019.07.010_bib0063","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0064","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1359\/jbmr.040116","article-title":"Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study","volume":"19","author":"McCloskey","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0066","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","article-title":"Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0067","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMoa0808692","article-title":"Lasofoxifene in postmenopausal women with osteoporosis","volume":"362","author":"Cummings","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jocd.2019.07.010_bib0068","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jocd.2019.07.010_bib0069","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jocd.2019.07.010_bib0070","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2011-3479","article-title":"Randomized teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk","volume":"97","author":"Nakamura","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.jocd.2019.07.010_bib0071","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jocd.2019.07.010_bib0072","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0073","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ard.2005.044958","article-title":"Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study","volume":"65","author":"Reginster","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.jocd.2019.07.010_bib0074","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"Boonen","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0075","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/jc.2014-4079","article-title":"A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial","volume":"100","author":"Langdahl","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.jocd.2019.07.010_bib0076","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0077","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00198-011-1856-y","article-title":"The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures","volume":"23","author":"Hadji","year":"2012","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jocd.2019.07.010_bib0078","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jocd.2019.07.010_bib0079","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JCD:7:3:255","article-title":"Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk","volume":"7","author":"Watts","year":"2004","journal-title":"J Clin Densitom"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0080","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.1644","article-title":"Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Jacques","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2019.07.010_bib0081","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.1472","article-title":"Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures","volume":"27","author":"Austin","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0082","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10133","key":"10.1016\/j.jocd.2019.07.010_bib0083","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(18)30756-6","article-title":"Teriparatide vs risedronate for osteoporosis \u2013 authors' reply","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet"},{"issue":"10117","key":"10.1016\/j.jocd.2019.07.010_bib0084","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0085","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","article-title":"Change in bone density and reduction in fracture risk: a meta-regression of published trials","volume":"34","author":"Bouxsein","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0086","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1359\/jbmr.2002.17.11.1988","article-title":"Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis","volume":"17","author":"Rizzoli","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0087","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1185\/030079904125003566","article-title":"Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis","volume":"20","author":"Harris","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0088","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bone.2009.12.034","article-title":"Efficacy and safety of monthly ibandronate in men with low bone density","volume":"46","author":"Orwoll","year":"2010","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.jocd.2019.07.010_bib0089","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0090","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.jocd.2019.07.010_bib0091","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"Kurland","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0092","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1359\/jbmr.081214","article-title":"Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study","volume":"24","author":"Boonen","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jocd.2019.07.010_bib0093","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00296-005-0004-4","article-title":"Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study","volume":"26","author":"Ringe","year":"2006","journal-title":"Rheumatol Int"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0094","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3949\/ccjm.72.11.1033","article-title":"What is a \u201cfailure\u201d of bisphosphonate therapy for osteoporosis?","volume":"72","author":"Carey","year":"2005","journal-title":"Cleve Clin J Med"},{"issue":"12","key":"10.1016\/j.jocd.2019.07.010_bib0095","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"Diez-Perez","year":"2012","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0096","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00198-008-0659-2","article-title":"Inadequate responders to osteoporosis treatment: proposal for an operational definition","volume":"19","author":"Diez-Perez","year":"2008","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2019.07.010_bib0097","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/jbmr.2918","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2019.07.010_bib0098","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-018-4791-3","article-title":"A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk","author":"Nayak","year":"2019","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0099","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.3039","article-title":"Goal-directed treatment for osteoporosis: a progress report from the ASBMR-NOF Working Group on goal-directed treatment for osteoporosis","volume":"32","author":"Cummings","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2019.07.010_bib0100","article-title":"Comparison of BMD changes and bone formation marker levels 3 years after bisphosphonate discontinuation: FLEX and HORIZON-PFT Extension I Trials","author":"Kim","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0101","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1210\/jc.2002-020727","article-title":"Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers","volume":"87","author":"Christopher Gallagher","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0102","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00198-011-1547-8","article-title":"The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years","volume":"23","author":"Middleton","year":"2012","journal-title":"Osteoporosis Int"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bone.2009.03.652","article-title":"The effects of anti-resorptive therapies and estrogen withdrawal in adult scoliosis measured by sub-segmental vertebral BMD analysis","volume":"45","author":"Routh","year":"2009","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.jocd.2019.07.010_bib0104","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1359\/JBMR.040326","article-title":"Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the fracture intervention trial long-term extension","volume":"19","author":"Ensrud","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/jc.2009-1366","article-title":"Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment","volume":"95","author":"Hershman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jocd.2019.07.010_bib0106","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1210\/jc.2014-1193","article-title":"A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring","volume":"99","author":"McNabb","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0107","first-page":"396","article-title":"Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up","volume":"83","author":"Mortensen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jocd.2019.07.010_bib0108","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00198-018-4460-6","article-title":"Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density","volume":"29","author":"Naylor","year":"2018","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0109","first-page":"1492","article-title":"Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal","volume":"85","author":"Ravn","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2474-8-3","article-title":"The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis","volume":"8","author":"Deane","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0111","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.jocd.2019.07.010_bib0112","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0113","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2019.07.010_bib0114","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jocd.2019.07.010_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-142-3-200502010-00007","article-title":"Association between screening for osteoporosis and the incidence of hip fracture","volume":"142","author":"Kern","year":"2005","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0116","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jocd.2011.03.001","article-title":"Long-term versus short-term precision of dual-energy X-ray absorptiometry scans and the impact on interpreting change in bone mineral density at follow-up","volume":"14","author":"Kiebzak","year":"2011","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2019.07.010_bib0117","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1359\/jbmr.071019","article-title":"Factors affecting short-term bone density precision assessment and the effect on patient monitoring","volume":"23","author":"Leslie","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jocd.2019.07.010_bib0118","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jbmr.5650100704","article-title":"Reproducibility of DXA absorptiometry: a model for bone loss estimates","volume":"10","author":"Fuleihan","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2019.07.010_bib0119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jocd.2009.09.004","article-title":"Some physical and clinical factors influencing the measurement of precision error, least significant change, and bone mineral density in dual-energy x-ray absorptiometry","volume":"13","author":"Frimeth","year":"2010","journal-title":"J Clin Densitom"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695019301593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695019301593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:42:25Z","timestamp":1761082945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695019301593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1094695019301593"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2019.07.010","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeating Measurement of Bone Mineral Density when Monitoring with Dual-energy X-ray Absorptiometry: 2019 ISCD Official Position","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2019.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}